Crossfund Sicav-Crossinvest Swiss Opportunity Fund B EUR

Reference Data

ISIN LU1776393115
Valor Number
Bloomberg Global ID
Fund Name Crossfund Sicav-Crossinvest Swiss Opportunity Fund B EUR
Fund Provider Crossinvest SA Lugano, Switzerland
Phone: +41 91 911 88 88
E-Mail: info@crossinvest.ch
Web: www.crossinvest.ch
Fund Provider Crossinvest SA
Representative in Switzerland FundPartner Solutions (Suisse) SA
Genève 75
Distributor(s) FundPartner Solutions (Suisse) SA
Genève 3
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Sub-Fund is to achieve a long term capital growth in Swiss Francs by pursuing exposure opportunities to the Swiss market. The Sub-Fund is actively managed. The Sub-Fund has no benchmark index and is not managed in reference to a benchmark index.
Peculiarities

Fund Prices

Current Price * 124.34 EUR 13.01.2026
Previous Price * 125.09 EUR 12.01.2026
52 Week High * 125.22 EUR 09.01.2026
52 Week Low * 103.84 EUR 09.04.2025
NAV * 124.34 EUR 13.01.2026
Issue Price * 124.34 EUR 13.01.2026
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 44,784,207
Unit/Share Assets *** 245,365
Trading Information SIX

Performance

YTD Performance +0.84% 31.12.2025
13.01.2026
YTD Performance (in CHF) +0.98% 31.12.2025
13.01.2026
1 month +2.39% 15.12.2025
13.01.2026
3 months +5.67% 13.10.2025
13.01.2026
6 months +8.88% 14.07.2025
13.01.2026
1 year +12.92% 13.01.2025
13.01.2026
2 years +23.57% 15.01.2024
13.01.2026
3 years +24.60% 13.01.2023
13.01.2026
5 years +20.12% 13.01.2021
13.01.2026

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novartis AG Registered Shares 9.84%
Roche Holding AG 9.35%
Nestle SA 7.32%
Compagnie Financiere Richemont SA Class A 6.64%
UBS Group AG Registered Shares 6.43%
ABB Ltd 4.94%
Zurich Insurance Group AG 4.75%
Holcim Ltd 4.57%
Swiss Re AG 3.59%
Swiss Life Holding AG 3.52%
Last data update 30.09.2025

Cost / Risk

TER *** 2.266%
TER date *** 30.11.2025
Performance Fee *** 15.00%
PTR
Max. Management Fee *** 1.70%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.12.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)